Gevelot
Gévelot SA engages in the manufacture and sale of pumps and fluid technology products. It operates in France, other European Union countries, other European countries, the United States, Africa, Asia, and internationally. The company was founded in 1820 and is based in Levallois-Perret, France.
Gevelot (ALGEV) - Total Liabilities
Latest total liabilities as of June 2025: €54.03 Million EUR
Based on the latest financial reports, Gevelot (ALGEV) has total liabilities worth €54.03 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Gevelot - Total Liabilities Trend (2000–2024)
This chart illustrates how Gevelot's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Gevelot Competitors by Total Liabilities
The table below lists competitors of Gevelot ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cinclus Pharma Holding AB (publ)
F:J8P
|
Germany | €157.99 Million |
|
AGTech Holdings Limited
PINK:AGTEF
|
USA | $6.59 Billion |
|
MAYO Human Capital Inc.
TWO:6738
|
Taiwan | NT$172.79 Million |
|
Birko Birlesik Koyunlulular Mensucat Ticaret ve Sanayi AS
IS:BRKO
|
Turkey | TL76.78 Million |
|
KJTS
KLSE:0293
|
Malaysia | RM28.47 Million |
|
Oncopeptides AB (publ)
PINK:ONPPF
|
USA | $179.25 Million |
|
Stratec SE
PINK:STSEY
|
USA | $191.16 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Gevelot's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.82 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gevelot's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gevelot (2000–2024)
The table below shows the annual total liabilities of Gevelot from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €52.61 Million | -43.93% |
| 2023-12-31 | €93.83 Million | -2.07% |
| 2022-12-31 | €95.81 Million | +11.45% |
| 2021-12-31 | €85.97 Million | +3.97% |
| 2020-12-31 | €82.69 Million | -14.88% |
| 2019-12-31 | €97.14 Million | +9.45% |
| 2018-12-31 | €88.75 Million | -5.57% |
| 2017-12-31 | €93.99 Million | -38.35% |
| 2016-12-31 | €152.46 Million | +9.93% |
| 2015-12-31 | €138.70 Million | -1.83% |
| 2014-12-31 | €141.28 Million | +56.84% |
| 2013-12-31 | €90.08 Million | +25.97% |
| 2012-12-31 | €71.51 Million | -14.61% |
| 2011-12-31 | €83.75 Million | +5.39% |
| 2010-12-31 | €79.47 Million | +7.07% |
| 2009-12-31 | €74.22 Million | -22.06% |
| 2008-12-31 | €95.24 Million | -10.23% |
| 2007-12-31 | €106.09 Million | -0.52% |
| 2006-12-31 | €106.65 Million | +2.47% |
| 2005-12-31 | €104.08 Million | +38.57% |
| 2004-12-31 | €75.11 Million | +9.59% |
| 2003-12-31 | €68.54 Million | -8.28% |
| 2002-12-31 | €74.73 Million | +3.47% |
| 2001-12-31 | €72.22 Million | -84.90% |
| 2000-12-31 | €478.25 Million | -- |